Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer

NCT00477087 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Prostatic Neoplasms

Interventions

DRUG: Mitoxantrone
DRUG: GM-CSF

Sponsor

Stanford University

Collaborators

[object Object]